Kwas tolfenamowy w profilaktyce i terapii zespolu bezmlecznosci poporodowej u loch oraz w odchowie prosiat

• Autorzy: Kotowski K , Zmudzki J.

Warianty tytułu

EN

Tolfenamic acid in prophylaxis and therapy of agalactia syndrome in sows and their litters

• Języki publikacji: PL

Abstrakty

EN

The aim of the study was to examine the efficacy of Tofline in prophylaxis of MMA syndrome in sows and to determine the influence of the preparation on production effects. Experiments were performed in 2 farms with similar natural environment conditions. 60 sows and their 625 piglets were used in the study. In each farm randomly chosen animals were divided into 2 groups: experimental and control. There were 20 sows on farm A and 10 sows in farm B in each group. Each sow in the experimental group after parturition was injected intramuscularly with Tofline at a dose of 1 ml/20 kg of body weight. Sows from the control groups were not injected with any drugs. MMA syndrome was detected in a total of 7 sows (23.33%) in the experimental groups of both farms, whereas in 8 sows (26.66%) were infected in the control groups. Additionally, the sows were treated with commercially available antibiotics: Combi-Ject (Dopharma BV), Pen-Strep (Norbrook) or Oxyvet (Polfa) in doses recommended by the producers. Sows were treated with oxytocin in a dose 20-30 i.u. and Tofline at a dose of 1 ml/20 kg of body weight. The therapeutic effect after the first treatment was observed in 9 sows (60%). In 6 (40%) cases out of 15 the treatment was repeated, while in 2 cases the antibiotic was changed until a therapeutic effect was observed. Body weight and number of piglets at the day of birth was similar in all the examined groups. However, at the end of the trail, the beneficial production effects in piglets from sows of experimental groups concerning daily weight gain were statistically significant (p  0,05). In groups of piglets administered with Tolfine clinical signs of diarrhea were observed in 9 litters (30%), while in control groups 14 litters (46.66%) were affected. Fertility and culling rate also increased after administering Tolfine. A total of 90% of sows were successfully inseminated in the experimental groups, whereas in the control groups the total was 83.34%.

Słowa kluczowe

PL

wyniki odchowu; preparat Tolfine; wyniki produkcyjne; zastosowanie; skutecznosc; prosieta; bezmlecznosc poporodowa; kwas tolfenamowy; leczenie; syndrom MMA; trzoda chlewna; profilaktyka; lochy

• Wydawca: -
• Czasopismo: Medycyna Weterynaryjna
• Rocznik: 2007
• Tom: 63
• Numer: 11
• Opis fizyczny: s.1342-1345,tab.,bibliogr.

Twórcy

autor

Kotowski K

• Panstwowy Instytut Weterynaryjny - Panstwowy Instytut Badawczy, Al.Partyzantow 57, 24-100 Pulawy

autor

Zmudzki J.

Bibliografia

• 1.Anon.: Normy Zywienia świñ. Omnitech Press, Warszawa 1993.
• 2.Bednarek D., Zdzisinska B., Kondracki M., Rzeski W., Paduch R., Kandefer- -Szerszeñ M.: A comparative study of the effects of meloxicam and flunixin meglumine (NSAIDs) as adjunctive therapy on interferon and tumor necrosis factor production in calves suffeiring from enzootic bronchopneumonia. Pol. J. Vet. Sci. 2003, 6, 109-115.
• 3.Bilkei G., Goos Th.: Evaluation of the occurence of SUGD (Swine Urogenital Disease) in large pig production unit. Proc. Congr. IPVS, Thailand 1994, s. 472.
• 4.Bostedt H., Maier G., Kerstin Herfen, Hospes R.: Klinische Erhebungen bei Sauen mit puerperaler Septikamie und Toxanie. Tierärztl. Prax. 1998, 26, 332-338.
• 5.Bossow H., Bodiker R., Richter H.: Artificial infection of vagina for the prevention of Metritis, Mastitis and Colibacillosis. Proc. Congr. IPVS, Thailand 1994, s. 375.
• 6.Cerne F., Jerkovic I., Debeljak C.: Influence of Finadyne (R) on some clinical sings of MMA. Proc. Congr. IPVS, Ghent 1984, s. 290.
• 7.Danek J.: Wpływ lipopolisacharydu i fluniksyny na stężenie steroidów płciowych i biochemiczne wskaŸniki nasienia ogierów. Medycyna Wet. 2006, 62, 713-716.
• 8.Hirsch A. C., Philipp H., Kleemann R.: Investigation on the efficacy of meloxicam in sows with mastitis-metritis-agalactia syndrome. J. Vet. Pharmacol. Therap. 2003, 26, 355-360.
• 9.Kotowski K.: Aktualne poglądy na występowanie zespołu MMA u loch. Życie Wet. 1997, 72, 50-53.
• 10.Kotowski K., Szrom A., Duœ R.: Skutecznoœæ preparatu Finadyne w profilaktyce i terapii zespołu MMA u loch. Medycyna Wet. 2006, 62, 1252-1255.
• 11.Landoni M. F., Cunningham F. M., Lees P.: Comparative pharmacodynamics of flunixin, ketoprofen and tolfenamic acid in calves. Vet. Rec. 1995, 137, 428-431.
• 12.Landoni M. F., Cunningham F. M., Lees P.: Pharmacokinetics and pharmacodynamics of tolfenamic acid in calves. Res. Vet. Sci. 1996, 61, 26-32.
• 13.Lofstedt J. A., Ross R. F., Wagner W. C.: Depression of polymarphonuclear leukocyte function associated with experimentally induced Escherichia coli mastitis in sows. Am. J. Vet. Res. 1983, 44, 1224-1228.
• 14.Pejsak Z., Kopczewski A., Błaszczyk B., Sadoch L.: Profilaktyka swoista w ograniczeniu strat spowodowanych bezmlecznością poporodową loch. Życie Wet. 1990, 65, 69-71.
• 15.Rekiel A.: Bezmleczność poporodowa loch etiologia i profilaktyka. Medycyna Wet. 1999, 55, 440-444.
• 16.Rekiel A.: Wpływ poziomu żywienia w okresie zasuszania na zdrowotnoœæ gruczołu mlekowego loch. Medycyna Wet. 2002, 58, 40-44.
• 17.Smith B., Wagner W. C.: Suppresion of prolactin in pigs by Escherichia coli endotoxin. Science 1984, 224, 605-606.
• 18.Tarasiuk K.: Bezmlecznoœæ poporodowa u loch występowanie, straty oraz ocena skutecznoœci immunoprofilaktyki. Praca dokt., Inst. Wet. Puławy 1988.
• 19.Truszczyñski M., Pejsak Z., Tarasiuk K.: Role of endotoxin, measured with the LAL test, in Coliform Mastitis of sows. Proc. Congr. IPVS, Rio de Janeiro 1988, s. 303.
• 20.Wojciechowski M.: Choroby zwyrodnieniowe stawów u psów. Cz. III. Rozpoznanie i leczenie. Życie Wet. 2005, 80, 707-714.